Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants
Clinical trial NCT05107336 · COMPLETED
Trial details
- NCT number
- NCT05107336
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-25
- Primary completion
- 2023-03-21
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.